Bjelica, Bogdan
Wohnrade, Camilla
Cespedes, Iraima
Osmanovic, Alma
Schreiber-Katz, Olivia
Petri, Susanne
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 21 September 2023
Accepted: 2 February 2024
First Online: 17 February 2024
Declarations
:
: This study was conducted in strict accordance with the principles outlined in the Declaration of Helsinki and in compliance with all relevant guidelines and regulations governing human research ethics. The study was approved by the Ethical Board of Hannover Medical School (no. 6269) and all patients gave written informed consent to participate.
: Not applicable.
: BB, CW and IC declare that they have no conflict of interests. AO has received speaker fees from Biogen GmbH outside the submitted work. O.S.-K. received academic research support from the Hannover Medical School (MHH) Young Faculty Program, 2018–2020, the “Ellen-Schmidt-Program” MHH (2021), and the German Neuromuscular Society “Deutsche Gesellschaft fuer Mus-kelkranke” (DGM e.V.), 2019–2021 (grant no. Sc 23/1); and received honoraria as a speaker/consultant and/or funding for travel expenses from the German Neuromuscular Society “Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.), Biogen GmbH, Biermann Verlag GmbH, and MK + S—Medizin, Kommunikation & Service GmbH, outside the submitted work. SP has received speaker fees, non-financial support and research support from Biogen, Roche, AL-S Pharma, Amylyx, Cytokinetics, Ferrer, ITF-Pharma, and Sanofi and served on advisory boards of Amylyx, Biogen, Roche, Zambon and ITF Pharma outside of the submitted work.